Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | 2C5H7NO4.Mg.2H.4H2O |
| Molecular Weight | 388.6088 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H+].[H+].O.O.O.O.[Mg++].N[C@@H](CCC([O-])=O)C([O-])=O.N[C@@H](CCC([O-])=O)C([O-])=O
InChI
InChIKey=ZWCGDRSVJYJGFY-GYDBBPQESA-L
InChI=1S/2C5H9NO4.Mg.4H2O/c2*6-3(5(9)10)1-2-4(7)8;;;;;/h2*3H,1-2,6H2,(H,7,8)(H,9,10);;4*1H2/q;;+2;;;;/p-2/t2*3-;;;;;/m00...../s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/680616 | http://www.druginfosys.com/drug.aspx?drugcode=1321&type=1https://noshly.com/additive/e625/flavour-enhancer/625/ | http://www.thegoodscentscompany.com/data/rw1609401.html | http://www.foodadditiveslist.com/page/55/ | http://www.fao.org/ag/agn/jecfa-additives/specs/Monograph1/Additive-259.pdf
Sources: https://www.ncbi.nlm.nih.gov/pubmed/680616 | http://www.druginfosys.com/drug.aspx?drugcode=1321&type=1https://noshly.com/additive/e625/flavour-enhancer/625/ | http://www.thegoodscentscompany.com/data/rw1609401.html | http://www.foodadditiveslist.com/page/55/ | http://www.fao.org/ag/agn/jecfa-additives/specs/Monograph1/Additive-259.pdf
Food additive, flavour enhancer, salt substitute - iImproves the taste and/or aroma of foods.
Approval Year
Sample Use Guides
In Vivo Use Guide
Curator's Comment: Rats were given diet containing 5% monocalcium di-L-glutamate tetrahydrate (Ca-glutamate), 2.5% monomagnesium di-L-glutamate tetrahydrate (Mg-glutamate), 5% L-glutamic acid, 5% monocalcium di-L-ascorbate dihydrate (Ca-ascorbate), 2.5% monomagnesium di-L-ascorbate dihydrate (Mg-ascorbate), or 5% L-ascorbic acid for 16 wk.
In a long-term study 19 young females were treated with Psychoverlan capsules or syrup for an average of 11.4 months.
Magnesium positive role is not only for the psychiatric illness but study highlight about the auditory brain stem problem in a study found use of super aliments of magnesium auditory brain stem problem reduced. Magnesium ideal dose is 125-300 mg /day.
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
INS-626
Created by
admin on Sat Dec 16 10:09:50 GMT 2023 , Edited by admin on Sat Dec 16 10:09:50 GMT 2023
|
PRIMARY | |||
|
129160-51-6
Created by
admin on Sat Dec 16 10:09:50 GMT 2023 , Edited by admin on Sat Dec 16 10:09:50 GMT 2023
|
PRIMARY | |||
|
S8TL3KXK0I
Created by
admin on Sat Dec 16 10:09:50 GMT 2023 , Edited by admin on Sat Dec 16 10:09:50 GMT 2023
|
PRIMARY | |||
|
71311557
Created by
admin on Sat Dec 16 10:09:50 GMT 2023 , Edited by admin on Sat Dec 16 10:09:50 GMT 2023
|
PRIMARY | |||
|
INS-625
Created by
admin on Sat Dec 16 10:09:50 GMT 2023 , Edited by admin on Sat Dec 16 10:09:50 GMT 2023
|
PRIMARY | |||
|
SUB68830
Created by
admin on Sat Dec 16 10:09:50 GMT 2023 , Edited by admin on Sat Dec 16 10:09:50 GMT 2023
|
PRIMARY | |||
|
100000134894
Created by
admin on Sat Dec 16 10:09:50 GMT 2023 , Edited by admin on Sat Dec 16 10:09:50 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
